Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

13 Oct 2021 07:00

RNS Number : 8661O
Centaur Media PLC
13 October 2021
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

 

13 October 2021

Centaur Media Plc

("Centaur" or the "Company")

Trading Update & Capital Markets Day

Centaur Media Plc, an international provider of business information, training and specialist consultancy, is pleased to announce an update on trading for the period ended 30 September 2021 and its outlook for the full year. The Company is also hosting its 2021 Capital Markets Day today.

 

Trading Update

 

Since the publication of the Company's Interim Results on 21 July 2021, the Board is pleased to announce that Centaur has continued to experience strong trading conditions enabling it to grow its revenues and adjusted1 EBITDA across both Xeim and The Lawyer.

 

Centaur's Brands continue to perform in line with its Margin Acceleration Plan (MAP23) objectives, notably:

 

Econsultancy is seeing subscriptions outperform management expectations, mainly through a sustained level of new business wins and demand for its blended learning proposition. Delivery of its training offering is on track.

The Marketing Week Mini MBA had another period of high double-digit growth driven by increased delegate numbers and price increases.

Influencer Intelligence is recovering as its new business and renewal rates are starting to rise following the significant impact of Covid on its smaller PR and fashion customers.

The Lawyer is ahead of target on corporate renewal rates, while billings are on track for its new Signal product, a subscription service offering in-depth strategic insight and benchmarking of markets, clients and competitors. Recruitment advertising has shown a strong recovery since 2020.

 

Next week, Centaur will be hosting the pinnacle in its events calendar, the Festival of Marketing: The Year Ahead. The four-day virtual event with live Q&As and video-on-demand will feature over 80 speakers, including the senior marketing leaders of several high profile brands such as Mastercard, Tesco, Coca-Cola, Diageo and Virgin, who will be joined by leading marketing academics Byron Sharp and Mark Ritson, as well as John Cleese, Eddie Izzard and Richard Curtis. The Lawyer is also hosting a number of events in Q4 including next week's hybrid In-House Counsel as Business Partner and next month's The Lawyer Awards.

 

Centaur's net cash balance stood at £12.4m as at 30 September 2021 (£11.9m as at 30 June 2021).

 

2021 Full Year Outlook

 

The Board expects full-year revenues to exceed £37m, a 15% year-on-year increase and at the top end of market expectations. Margins in H2 2021 continue to improve, with adjusted1 EBITDA margin for FY 2021 expected to be approximately 15%.

 

Xeim, our business unit serving the marketing sector, is expected to report a year-on-year underlying revenue increase of at least 17% with The Lawyer expecting to report an underlying revenue increase of at least 7%.

 

The Board remains confident in the successful delivery of Centaur's revenue and EBITDA margin objectives as set out under MAP23.

 

Capital Markets Day

 

Centaur will today hold a Capital Markets Day for institutional investors and analysts. The event will be hosted by Swag Mukerji, CEO, and Simon Longfield, CFO, together with a number of the senior management team from across the Company.

 

The Capital Markets Day will cover Centaur's strategic progress, while providing further detail on its Flagship 4 and Core Brands and outlining the role of these brands within the Company's MAP23 strategy.

 

The presentations will commence at 10:00 BST. A recording will subsequently be made available on the Company's website.

 

No further trading information will be disclosed during the event.

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation on a post-IFRS 16 basis. Adjusted results exclude adjusting items, such as exceptional items, as detailed in note 4 of the Interim Report for the period ended 30 June 2021.

 

Enquiries

Centaur Media Plc

020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt / Matthew Thomlinson

07713 157561 / 07785 528363

Note to editors

Centaur is an international provider of business information, training and specialist consultancy that inspires and enables people to excel at what they do, raising the standard for insight, interaction and impact.  Leading brands include The Lawyer, Econsultancy, Influencer Intelligence, MW Mini MBA, Marketing Week, Festival of Marketing, Creative Review, Fashion & Beauty Monitor, Oystercatchers and Really B2B.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUAKRANURAAA
Date   Source Headline
25th Jul 201712:27 pmRNSResult of General Meeting
25th Jul 201711:00 amRNSDirectorate Change
19th Jul 20174:27 pmRNSDirector/PDMR Shareholding
14th Jul 20173:41 pmRNSNotice of Results
11th Jul 20172:51 pmRNSHolding(s) in Company
7th Jul 20172:47 pmRNSPublication of Circular
7th Jul 20177:00 amRNSProposed Disposal and Proposed Acquisition
30th Jun 20177:00 amRNSTotal Voting Rights
19th Jun 20174:15 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
24th May 201710:44 amRNSHolding(s) in Company
22nd May 201712:26 pmRNSDirector/PDMR Shareholding
9th May 20174:32 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
8th May 201710:32 amRNSHolding(s) in Company
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20174:22 pmRNSDirector/PDMR Shareholding
21st Apr 20171:27 pmRNSDirector/PDMR Shareholding
11th Apr 20173:37 pmRNSGrant of Award under LTIP
10th Apr 20174:40 pmRNSSecond Price Monitoring Extn
10th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20173:09 pmRNSAnnual Report and Notice of AGM
3rd Apr 20179:21 amRNSTotal Voting Rights
29th Mar 20177:05 amRNSPotential disposal of Home Interest
29th Mar 20177:00 amRNSFinal Results
21st Mar 20173:07 pmRNSDirector/PDMR Shareholding
7th Mar 20173:37 pmRNSNotice of Results
6th Mar 201710:55 amRNSHolding(s) in Company
28th Feb 20179:38 amRNSTotal Voting Rights
21st Feb 201710:31 amRNSDirector/PDMR Shareholding
31st Jan 20174:00 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSTrading Update
23rd Jan 201710:07 amRNSHolding(s) in Company
19th Jan 20176:15 pmRNSDirector/PDMR Shareholding
30th Dec 20167:00 amRNSTotal Voting Rights
20th Dec 20164:18 pmRNSDirector/PDMR Shareholding
14th Dec 20167:00 amRNSTransaction in Own Shares
8th Dec 20167:00 amRNSTransaction in Own Shares
7th Dec 20167:00 amRNSTransaction in Own Shares
6th Dec 20169:13 amRNSTransaction in Own Shares
2nd Dec 20165:04 pmRNSTransaction in Own Shares
2nd Dec 20167:00 amRNSTransaction in Own Shares
30th Nov 20166:01 pmRNSTotal Voting Rights
30th Nov 20165:58 pmRNSTransaction in Own Shares
30th Nov 20167:00 amRNSTransaction in Own Shares
28th Nov 20165:39 pmRNSTransaction in Own Shares
25th Nov 20163:52 pmRNSTransaction in Own Shares
24th Nov 20165:23 pmRNSTransaction in Own Shares
24th Nov 20167:00 amRNSTransaction in Own Shares
23rd Nov 20167:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.